Home
>
US Stocks
>
Ocular Therapeutix Inc
Ocular Therapeutix Inc
OCUL

Ocular Therapeutix Inc

$11.225.45%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
11.6
Today Low/High
11.11 / 11.6
52 Week Low/High
$7.14 / $24.3
Market Cap
$780.38M

Company Details

Ocular Therapeutix, Inc. is a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary bioresorbable hydrogel-based formulation technology. Ocular Therapeutix's first commercial drug product, DEXTENZA (dexamethasone ophthalmic insert) 0.4 mg for intracanalicular use, is FDA-approved for the treatment of ocular inflammation and pain following ophthalmic surgery. Ocular Therapeutix has also submitted a Supplemental NDA for DEXTENZA to include the treatment of ocular itching associated with allergic conjunctivitis as an additional approved indication. Ocular Therapeutix's earlier stage development assets currently in Phase 1 clinical trials include OTX-TKI (axitinib intravitreal implant) for the treatment of wet AMD and other retinal diseases and OTX-TIC (travoprost intracameral implant) for the reduction of intraocular pressure in patients with primary open-angle glaucoma or ocular hypertension. Ocular Therapeutix is currently evaluating each of OTX-CSI (cyclosporine intracanalicular insert) for the chronic treatment of dry eye disease and OTX-DED (dexamethasone intracanalicular insert) for the short-term treatment of the signs and symptoms of dry eye disease in Phase 2 clinical trials. Also, in collaboration with Regeneron, OTX-AFS (aflibercept suprachoroidal injection) is in pre-clinical development as an extended-delivery formulation of aflibercept for the treatment of retinal diseases. Ocular Therapeutix's first product, ReSure® Sealant is an FDA-approved device to prevent wound leaks in corneal incisions following cataract surgery.
Organisation
Ocular Therapeutix Inc
Headquaters
Bedford, Massachusetts, US
Employees
181
Industry
Health Technology
CEO
Antony Mattessich

Discover more

Frequently Asked Questions

What is Ocular Therapeutix Inc share price today

Can Indians buy Ocular Therapeutix Inc shares?

How can I buy Ocular Therapeutix Inc shares from India?

Can Fractional shares of Ocular Therapeutix Inc be purchased?

What are the documents required to start investing in Ocular Therapeutix Inc stocks?

We are a SEBI registered investement advisor